Goal 1
ANNUAL
REPORT 2023
Goal 1
ANNUAL
REPORT 2023
Goal 1
ANNUAL
REPORT 2023
Goal 1: Conduct high-quality, multidisciplinary, practice-changing clinical trials in urogenital* cancers
ANZUP is an organisation that brings together a diverse group of professionals involved in the treatment and research of genitourinary cancers, as well as individuals who have been diagnosed with or have personal experience of these cancers.
ANZUP’s diverse membership base ensures we develop robust, high quality clinical trials. Our trials cover a wide range of tumour types, including prostate, kidney, bladder, testicular, and penile cancers. We also explore various treatment approaches such as nuclear medicine, immunotherapy, online psychotherapy, and other supportive care resources.
The Principal Investigators (PIs) across ANZUP trials specialise in a range of areas including urology, surgery, radiation oncology, medical oncology, nursing and psychology. ANZUP continues to ensure the trial lead investigators are multidisciplinary, in efforts to have all-inclusive input into the research undertaken.
We also prioritise the involvement of junior researchers from all disciplines. ANZUP encourages their participation by inviting them to attend our events and workshops, including the Best of GU meetings, Rapid Fire symposium, MDT Masterclasses, and Ideas Generation Workshops. By providing these opportunities, we aim to foster the growth and contributions of the next generation of researchers.
Regular analysis and reporting take place within each subcommittee, covering concepts submitted, trials in development, ongoing trials, and the pipeline. These updates are shared during quarterly meetings, conducted face-to-face and via Zoom.
The Ideas Generation Workshops, run across each of the five cancers ANZUP represents, and all subcommittee members are encouraged to use these events to submit, consider and review new concepts.
ANZUP ensures effective communication with its members through the Monthly Trial UPdate, which aims to enhance patient recruitment to ANZUP trials and promote cross-referrals. The UPdate provides valuable information about trial recruitment, upcoming events and workshops, as well as key highlights from ongoing trials.
To keep members informed about trial recruitment status, ANZUP regularly provides updates on various channels, including sessions held at the Annual Scientific Meeting (ASM), trial specific e-newsletters, social media and websites updates as well as the Trial Management Committees (TMC) meetings.
ANZUP actively collaborates with international partners involved in the ENZAMET and ENZARAD trials, organising a biannual International Trial Steering Committee meeting. This meeting, facilitated by ANZUP, serves as a platform for building and maintaining relationships with the international clinical trial community. It also enables the analysis of the genitourinary clinical trials landscape, identification of research gaps, and consideration of new concepts.
At the centre of ANZUP is the Scientific Advisory Committee (SAC), which plays a crucial role in fostering discussion among members about novel trial ideas. The SAC serves as a forum to progress proposals into established protocols, allowing for the development of innovative and impactful research initiatives.